Karuna Therapeutics SG&A Expense (Quarterly) Analysis

Karuna Therapeutics Inc (DELISTED) (KRTX:DL)

329.83 0.00 (0.00%) USD | NASDAQ | Mar 18, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	47.39M
September 30, 2023	32.27M
June 30, 2023	27.42M
March 31, 2023	24.25M
December 31, 2022	24.31M
September 30, 2022	19.12M
June 30, 2022	17.84M
March 31, 2022	14.79M
December 31, 2021	20.06M
September 30, 2021	12.39M
June 30, 2021	10.38M
March 31, 2021	9.777M

Date	Value
December 31, 2020	8.823M
September 30, 2020	6.944M
June 30, 2020	7.006M
March 31, 2020	5.635M
December 31, 2019	3.874M
September 30, 2019	4.103M
June 30, 2019	8.286M
March 31, 2019	4.606M
December 31, 2018	1.426M
September 30, 2018	1.056M
June 30, 2018	0.256M
March 31, 2018	0.236M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

3.874M

Minimum

Dec 2019

47.39M

Maximum

Dec 2023

16.04M

Average

12.39M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks